Mechanical Thrombectomy Global Access For Stroke (MT-GLASS): A Mission Thrombectomy (MT-2020 Plus) Study
Kaiz S. AsifFadar O. OtiteShashvat M. DesaiNabeel HerialVioliza InoaFawaz Al-MuftiAshutosh P. JadhavAdam A. DmytriwAlicia CastonguayPriyank KhandelwalJennifer Potter-VigViktor SzederTanzila KulmanVictor UrrutiaHesham MasoudGabor TothKaustubh LimayeSushanth AroorWaleed BrinjikjiAnsaar RaiJeyaraj PandianMehari GebreyohannsThomas LeungOssama MansourAndrew M. DemchukVikram HudedSheila MartinsOsama ZaidatXiaochuan HuoBruce CampbellP.N. SylajaZhongrong MiaoJeffrey SaverSantiago Ortega-GutierrezDileep R. YavagalAscension Health,Chicago,IL (K.S.A.).University of Illinois,Chicago (K.S.A.).SUNY Upstate Medical University,Syracuse,NY (F.O.O.).HonorHealth Research and Innovation Institute,Scottsdale,AZ (S.M.D.).Thomas Jefferson University,Philadelphia,PA (N.H.).Semmes-Murphey Neurologic and Spine Clinic,Memphis,TN (V.I.).New York Medical College,Valhalla,NY (F.A.-M.).Barrow Neurological Institute,Phoenix,AZ (A.P.J.).Massachusetts General Hospital,Boston (A.A.D.).University of Toledo,OH (A.C.).Rutgers New Jersey Medical School,Newark (P.K.).Society of Vascular and Interventional Neurology/MT2020,Minneapolis,MN (J.P.-V.).University of California,Los Angeles (V.S.,J.S.).Aultman Hospital,Canton,OH (T.K.).Johns Hopkins University School of Medicine,Baltimore,MD (V.U.).State University of New York,Syracuse (H.M.).Cleveland Clinic,OH (G.T.).Indiana University,Bloomington (K.L.).Rutgers University,Newark,NJ (S.A.).Mayo Clinic,Rochester,MN (W.B.).West Virginia University,Morgantown (A.R.).Christian Medical College,Vellore,India (J.P.).University of Texas Southwestern Medical Center,Dallas (M.G.).Prince of Wales Hospital,Randwick,Australia (T.L.).Alexandria University,Egypt (O.M.).Calgary Stroke Program,Canada (A.M.D.).NH Institute of Neurosciences,Bengaluru,Karnataka,India (V.H.).University of Rio Grande do Sul,Porto Alegre,Brazil (S.M.).St Vincent Mercy Medical Center,Toledo,OH (O.Z.).Beijing Tiantan Hospital,Capital Medical University,Beijing,China (X.H.,Z.M.).Royal Melbourne Hospital,University of Melbourne,Parkville,Australia (B.C.).Sree Chitra Tirunal Institute for Medical Sciences and Technology,Trivandrum,India (P.N.S.).University of Iowa,Iowa City (S.O.-G.).University of Miami Miller School of Medicine,FL (D.R.Y.).
DOI: https://doi.org/10.1161/CIRCULATIONAHA.122.063366
IF: 37.8
2023-03-09
Circulation
Abstract:Circulation, Ahead of Print. Background:Despite the well-established potent benefit of mechanical thrombectomy (MT) for large vessel occlusion (LVO) stroke, access to MT has not been studied globally. We conducted a worldwide survey of countries on 6 continents to define MT access (MTA), the disparities in MTA, and its determinants on a global scale.Methods:Our survey was conducted in 75 countries through the Mission Thrombectomy 2020+ global network between November 22, 2020, and February 28, 2021. The primary end points were the current annual MTA, MT operator availability, and MT center availability. MTA was defined as the estimated proportion of patients with LVO receiving MT in a given region annually. The availability metrics were defined as ([current MT operators×50/current annual number of estimated thrombectomy-eligible LVOs]×100 = MT operator availability) and ([current MT centers×150/current annual number of estimated thrombectomy-eligible LVOs]×100= MT center availability). The metrics used optimal MT volume per operator as 50 and an optimal MT volume per center as 150. Multivariable-adjusted generalized linear models were used to evaluate factors associated with MTA.Results:We received 887 responses from 67 countries. The median global MTA was 2.79% (interquartile range, 0.70–11.74). MTA was <1.0% for 18 (27%) countries and 0 for 7 (10%) countries. There was a 460-fold disparity between the highest and lowest nonzero MTA regions and low-income countries had 88% lower MTA compared with high-income countries. The global MT operator availability was 16.5% of optimal and the MT center availability was 20.8% of optimal. On multivariable regression, country income level (low or lower–middle versus high: odds ratio, 0.08 [95% CI, 0.04–0.12]), MT operator availability (odds ratio, 3.35 [95% CI, 2.07–5.42]), MT center availability (odds ratio, 2.86 [95% CI, 1.84–4.48]), and presence of prehospital acute stroke bypass protocol (odds ratio, 4.00 [95% CI, 1.70–9.42]) were significantly associated with increased odds of MTA.Conclusions:Access to MT on a global level is extremely low, with enormous disparities between countries by income level. The significant determinants of MT access are the country's per capita gross national income, prehospital LVO triage policy, and MT operator and center availability.
cardiac & cardiovascular systems,peripheral vascular disease